Investors

<p>Close up of a middle aged woman dressed in a blazer, sitting down while looking at another person in the foreground.</p>

Welcome to Mendus’ Investor Relations page. Mendus is listed on NASDAQ Stockholm under the ticker symbol IMMU. You will find all relevant information on the Mendus share in our Investors section.

Events & Presentations

    2022

    2022

    Upcoming

    Sachs 22nd Annual Biotech in Europe Forum

    The 22nd Annual Biotech in Europe Forum will take place in-person on September 21-22, 2022, at the Mövenpick Hotel in Basel, Switzerland. Mendus' CEO Erik Manting will present on September 21, 2022.
    Learn more
    Upcoming

    Pareto Securities’ 13th Annual Healthcare Conference

    On 7-8 September 2022, Pareto Securities will host its 13th Annual Healthcare Conference. Mendus' CEO Erik Manting will present at the conference.
    Learn more
    Upcoming

    LSX Nordic Congress 2022

    The LSX Nordic Congress will take place on 6-7 September, 2022, at the AC Hotel Bella Sky in Copenhagen, Denmark. Mendus' CEO Erik Manting will present on June 6, 2022.
    Learn more
    Upcoming

    Publication of Q2 2022 Results

    Mendus will publish the results of the second quarter and first six month of 2022 on August 26th, 2022 at 8am CET.
    Previous

    BIO International Convention

    Our BD team participated in the BIO International Convention, June 13-16, 2022, in San Diego, USA.
    Learn more
    Previous

    EHA2022 Congress

    Our management team participated in the EHA2022 Congress, June 9-17, 2022 in Vienna, Austria.
    Learn more
    Previous

    BioStock Life Science Spring Summit

    Our CEO Erik Manting presented on June 9, at 10:20 am CET. A replay is available using the link below.
    Learn more
    Previous

    Redeye Growth Day 2022

    Mendus' CEO Erik Manting participated in an on-site Q&A session on June 2.
    Learn more
    Previous

    ADVANCE II – Interim Results Webcast

    On May 16th, Immunicum announced updated interim results from the ongoing ADVANCE II clinical trial. To view the webcast presentation, please use the link below.
    Learn more
    Previous

    Kempen’s 14th Life Sciences Conference

    Mendus' CEO Erik Manting presented on Thursday, April 21, at 1:30 pm CET.
    Learn more